Roche Presents New Data for OCREVUS and Fenebrutinib Across Broad Patient ... - MarketScreener

Retrieved on: 2025-09-24 14:38:27

Tags for this article:

Multiple sclerosis

Autoimmune diseases

Monoclonal antibodies

Research in multiple sclerosis

Ocrelizumab

Fenebrutinib

Bruton's tyrosine kinase

Expanded Disability Status Scale

EDSS

Multiple sclerosis drug pipeline

Click the tags to see associated articles and topics

Roche Presents New Data for OCREVUS and Fenebrutinib Across Broad Patient ... - MarketScreener. View article details on hiswai:

Excerpt

Roche presents new data for OCREVUS®? and the investigational Bruton's tyrosine kinase inhibitor fenebrutinib at the 41st Congress of the European ...

Article found on: www.marketscreener.com

View Original Article